PTGX
Protagonist Therapeutics, Inc.
Stock
$140.06+0.87 (+0.63%)Close Oct 2, 2026
- Free cash flow, 2025
- $56M
- YoY, 2025
- −69.3%
Free cash flow
Free cash flow by fiscal year
| Period | Free cash flow | YoY |
|---|---|---|
| 2025 | $56M | −69.3% |
| 2024 | $183M | — |
| 2023 | −$71M | — |
| 2022 | −$109M | — |
| 2021 | −$109M | — |
| 2020 | −$73M | — |
| 2019 | −$42M | — |
| 2018 | −$50M | — |
| 2017 | $3.2M | — |
| 2016 | −$30M | — |
| 2015 | −$15M | — |
| 2014 | −$8.0M | — |